Summary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old…
Pfizer
-
-
CompaniesPfizer
Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
by adminby adminSynopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
-
AgrochemicalsPharma Science & Research
Three exposures to spike protein allow people to develop broad antibody immunity – also against Omicron
by adminby adminSummary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is…
-
CompaniesPfizer
Pfizer Alleges Stolen Trade Secrets at Heart of Regor Therapeutics Launch
by adminby adminSynopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit…
-
CompaniesPfizer
Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
-
CompaniesPfizerPharma Science & Research
Pfizer Abandons Ionis’ Cardiovascular and High Triglyceride Program
by adminby adminSummary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…
-
Agrochemicals
Delta variant, waning immunity reduced Pfizer vaccine’s effectiveness against household transmission
by adminby adminSummary : A new study by Yale School of Public Health (YSPH) researchers suggests that the Pfizer-BioNTech vaccine was more than 91%…
-
AgrochemicalsGlobal Market
Singapore approves Covid-19 vaccine boosters for age 12-17s
by adminby adminSummary : Singapore will extend its COVID-19 booster vaccination programme to adolescents aged 12 to 17 years from next month, its health…
-
CompaniesGlobal MarketPfizerPharma Science & Research
Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies…
-
Pharma Science & Research
Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against Omicron Variant
by adminby adminSynopsis : Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active…